Overview

• Hinge Health priced its IPO at $32 per share, the top of its expected range, raising $273 million by selling 8.52 million new shares.
• The company’s public valuation of $2.6 billion marks a significant drop from its $6.2 billion private valuation in 2021.
• Hinge Health reported strong financial performance in Q1 2025, with 50% year-over-year revenue growth to $123.8 million and a $17.1 million profit after a prior loss.
• The startup, founded in 2014, provides AI-powered solutions for remote musculoskeletal therapy, addressing chronic pain, acute injuries, and post-surgery rehab.
• Industry analysts view the IPO as a key test for reviving investor interest in digital health companies after a prolonged market downturn.